Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 Phase II Clinical Trial
AUSTIN, Texas, April 6, 2022 /PRNewswire/ — Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC)
Read MoreAUSTIN, Texas, April 6, 2022 /PRNewswire/ — Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC)
Read More